Uniqa Insurance: Strong Earnings Clash with Share Price Weakness

Uniqa Insurance Group has reported a substantial surge in profit for the 2025 financial year, a development that stands in stark contrast to a significant recent correction in its share price. The company’s net result advanced by 22 percent, yet its stock declined by more than 12 percent over the past month. This divergence between robust fundamentals and short-term market sentiment currently defines the narrative surrounding the insurer.

Operational Strength and Strategic Focus

The group’s net profit for the past year rose to €424.8 million. Operational efficiency was a key highlight, with a highly profitable claims-cost ratio of 91.7 percent. Premium income climbed to a total of €8.36 billion, representing solid growth of 8.2 percent compared to the previous period.

Management continues to prioritize a strategy focused on sustainable profitability over short-term effects. This fortified operational base raises the question of whether it will be sufficient to counter investor skepticism following the recent share price slide.

Chart Analysis and Technical Support

Despite the positive fundamental news, Uniqa shares were quoted at €14.70 on Friday. This price marks a decline of 12.29 percent over a 30-day period, moving the stock notably away from its 52-week high of €16.96, which was reached in late February.

Should investors sell immediately? Or is it worth buying Uniqa Insurance?

A potential silver lining exists in the technical picture: at €14.70, the equity continues to trade approximately 6 percent above its 200-day moving average of €13.87. This long-term trend line frequently acts as a crucial level of support for the price.

Southeast Europe Drives Growth

Expansion in Southeast Europe remains a fundamental pillar of the company’s performance. The region generated a pre-tax profit of €36.2 million. Developments in Bulgaria were particularly noteworthy:

• Bulgarian Premium Growth: +12.9% to €101.1 million
• Bulgarian Pre-Tax Profit: €6.5 million
• Bulgarian Combined Ratio: An excellent 83.5%
• Primary Growth Driver: Supplementary health insurance products

In Bulgaria alone, this segment contributed €11.5 million to the result, underscoring the importance of specialized insurance products for the overall group’s margin.

For the ongoing 2026 financial year, the executive board plans to further consolidate core business operations in existing markets. The implementation of this strategy in the coming quarters will determine if the share price can translate the fundamental strength of the 2025 results into tangible gains for investors.